Deploying $15.6 Million for Patient Assistance in Cell and Gene Therapy Trials...But Not Tomorrow
CIRM plan will not really start for another year
Seventeen months after California voters charged the $12 billion stem cell agency with doing something about the astronomical expenses of its potential therapies, the agency is on the cusp tomorrow of taking a tiny, tiny step forward.
Much more remains to be done, however, to comply with the affordability mandate of Proposition 14 …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.